A novel tissue-engineered 3D tumor model for anti-cancer drug discovery

2018 ◽  
Vol 11 (1) ◽  
pp. 015004 ◽  
Author(s):  
Wenfang Li ◽  
Xueyan Hu ◽  
Shuaitao Yang ◽  
Shuping Wang ◽  
Chenghong Zhang ◽  
...  
Keyword(s):  
Drug Discovery ◽  
Tumor Model ◽  
Cancer Drug ◽  
Cancer Drug Discovery ◽  
Anti Cancer

Natural Sesquiterpene Lactones in the Prevention and Treatment of Inflammatory Disorders and cancer: A Systematic Study of this Emerging Therapeutic Approach based on Chemical and Pharmacological Aspect

2020 ◽  
Vol 17 (9) ◽  
pp. 1102-1116
Author(s):  
Sudip Kumar Mandal ◽  
Utsab Debnath ◽  
Amresh Kumar ◽  
Sabu Thomas ◽  
Subhash Chandra Mandal ◽  
...  
Keyword(s):  
Drug Discovery ◽  
Biological Activities ◽  
Sesquiterpene Lactones ◽  
Structural Diversity ◽  
Cancer Drug ◽  
Cancer Drug Discovery ◽  
Anti Cancer ◽  
Drug Discovery Program ◽  
Anti Inflammatory ◽  
Family Based

Background and Introduction: Sesquiterpene lactones are a class of secondary metabolite that contains sesquiterpenoids and lactone ring as pharmacophore moiety. A large group of bioactive secondary metabolites such as phytopharmaceuticals belong to this category. From the Asteraceae family-based medicinal plants, more than 5,000 sesquiterpene lactones have been reported so far. Sesquiterpene lactone-based pharmacophore moieties hold promise for broad-spectrum biological activities against cancer, inflammation, parasitic, bacterial, fungal, viral infection and other functional disorders. Moreover, these moiety based phytocompounds have been highlighted with a new dimension in the natural drug discovery program worldwide after the 2015 Medicine Nobel Prize achieved by the Artemisinin researchers. Objective: These bitter substances often contain an α, β-unsaturated-γ-lactone as a major structural backbone, which in recent studies has been explored to be associated with anti-tumor, cytotoxic, and anti-inflammatory action. Recently, the use of sesquiterpene lactones as phytomedicine has been increased. This study will review the prospect of sesquiterpene lactones against inflammation and cancer. Methods: Hence, we emphasized on the different features of this moiety by incorporating its structural diversity on biological activities to explore structure-activity relationships (SAR) against inflammation and cancer. Results: How the dual mode of action such as anti-inflammatory and anti-cancer has been exhibitedby these phytopharmaceuticals will be forecasted in this study. Furthermore, the correlation of anti-inflammatory and anti-cancer activity executed by the sesquiterpene lactones for fruitful phytotherapy will also be revealed in the present review in the milieu of pharmacophore activity relation and pharmacodynamics study as well. Conclusion: So, these metabolites are paramount in phytopharmacological aspects. The present discussion on the future prospect of this moiety based on the reported literature could be a guide for anti-inflammatory and anti-cancer drug discovery programs for the upcoming researchers.

Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery

2016 ◽  
Vol 16 (10) ◽  
pp. 1339-1352 ◽  
Author(s):  
Alessandra C. Pinheiro ◽  
Thais C. Mendonça Nogueira ◽  
Marcus V.N. de Souza
Keyword(s):  
Drug Discovery ◽  
Cancer Drug ◽  
Cancer Drug Discovery ◽  
Anti Cancer

scholarly journals PO-200 3DIn vitrocultures of PDX-derived tumour for anti-cancer drug discovery

2018 ◽  
Author(s):  
L Price ◽  
S Basten ◽  
K Yan ◽  
T Giesemann ◽  
J Schueler ◽  
...  
Keyword(s):  
Drug Discovery ◽  
Cancer Drug ◽  
Cancer Drug Discovery ◽  
Anti Cancer
Sign in / Sign up

Export Citation Format

Share Document